Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:326-333

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sachinidis, A.
Right arrow Articles by Vetter, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sachinidis, A.
Right arrow Articles by Vetter, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*CHOLESTEROL

(Hypertension. 1997;29:326.)
© 1997 American Heart Association, Inc.


Arthur C. Corcoran Memorial Lecture

Cholesterol Enhances Platelet-Derived Growth Factor-BB-Induced [Ca2+]i and DNA Synthesis in Rat Aortic Smooth Muscle Cells

Agapios Sachinidis; Min Liu; Artur-Aron Weber; Claudia Seul; Volker Harth; Stefan Seewald; Yon Ko; Hans Vetter

From the Medizinische Universitäts-Poliklinik, Bonn, Germany.

Correspondence to PD Dr A. Sachinidis, Medizinische Universitäts-Poliklinik, Wilhelmstr 35–37, 53111 Bonn, Germany

In the present study, we describe possible mechanisms by which hypercholesterolemia may contribute to the development of cardiovascular diseases. Treatment of rat aortic smooth muscle cells for 20 hours with cholesterol-rich liposomes (500 µg/mL cholesterol, 100 µg/mL low-density lipoprotein) resulted in a 76±12% increase in total cholesterol content. The effects of cholesterol enrichment were examined by determination of changes in cell membrane fluidity. Fluidity of the cholesterol-enriched cell membranes was decreased at all temperatures between 15°C and 40°C. Changes in membrane fluidity in whole cell membranes represented changes in fluidity of microsomal membranes isolated by Percoll gradient ultracentrifugation. The basal [Ca2+]i and the maximal platelet-derived growth factor (PDGF)-BB-induced [Ca2+]i was elevated by 30% and 90% in cholesterol-enriched cells, respectively. In contrast, the resting pHi and the PDGF-BB-induced stimulation of the Na+/H+ exchange were not affected in cholesterol-enriched cells. The effect of PDGF-BB on [3H]thymidine incorporation in cholesterol-enriched cells was elevated by 40% in comparison with untreated cells. Our findings show that cellular cholesterol may be involved in the development of vascular diseases via modulation of the PDGF-induced increase in [Ca2+]i and DNA synthesis in vascular smooth muscle cells.


Key Words: cholesterol • vascular smooth muscle cells • platelet-derived growth factor

Abbreviations: DMEM = Dulbecco’s modified Eagle’s medium • PC = dipalmitoylphosphatidylcholine • PDGF = platelet-derived growth factor • VSMC = vascular smooth muscle cell(s)




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. H. Rauch, G. A. Scholz, D. Baumgartel-Allekotte, P. Censarek, J. W. Fischer, A.-A. Weber, and K. Schror
Cholesterol Enhances Thrombin-Induced Release of Fibroblast Growth Factor-2 in Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): e20 - e25.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. GOUNI-BERTHOLD and A. SACHINIDIS
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
FASEB J, October 1, 2002; 16(12): 1477 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Sachinidis, R. Kettenhofen, S. Seewald, I. Gouni-Berthold, U. Schmitz, C. Seul, Y. Ko, and H. Vetter
Evidence That Lipoproteins Are Carriers of Bioactive Factors
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2412 - 2421.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Sachinidis, S. Seewald, P. Epping, C. Seul, Y. Ko, and H. Vetter
The Growth-Promoting Effect of Low-Density Lipoprotein May Be Mediated by a Pertussis Toxin-Sensitive Mitogen-Activated Protein Kinase Pathway
Mol. Pharmacol., September 1, 1997; 52(3): 389 - 397.
[Abstract] [Full Text]